Fiocruz News
Displaying 2221 - 2250 of 2491
The trial is conducted by more than 70 researchers and aims to evaluate the safety and efficacy of two different doses of drugs in severe patients.
As the disease moves to smallest cities, a marked increase in the rate of indigenous populations at high risk is also expected.
In the United States and in Ecuador, the interval necessary for this duplication is an average of 6 days. In Italy and in Spain, 8 days.
The production will help to implement a massive testing strategy in Brazil, as recommended by WHO
Saúde mental é preocupação institucional
Capacidade de procedimentos diários também salta de 8 para 20
Subnotificação da doença é um problema a ser enfrentado
Editais de 'Ideias e Produtos Inovadores' e de 'Geração de Conhecimento' estão abertos. A inclusão de grupos externos é bem-vinda, assim como será incentivada a criação de redes internas
Pesquisa, Produção
'United against Covid-19' is a channel for organizations and individuals interested in support Fiocruz initiatives to fight the pandemic
Espaço de apoio à gestão do novo hospital já funciona em Manguinhos
The Laboratory for Respiratory Viruses and Measles has been formally acknowledged as reference in the continent, together with the CDC
Starting this year, April 14th will serve to give visibility in the global health agenda to the challenges faced by patients of Chagas disease
A study has observed that the drug Atazanavir was able to inhibit viral replication and to reduce the production of proteins that are related to the inflammatory process in the lungs.
The initiative of more than 70 scientists and institutions of 30 countries aims to guarantee access to advances in the research to developing countries and vulnerable populations
Leaders of more than 30 global health institutions shared their experience in the fight against Covid-19 and the creation of a safe and gradual strategy for the post-quarantine.
Nísia Trindade Lima comments on the context of the pandemic, its challenges and the institutional response to the health crisis.
Scientists all over the world will be able to have quick access to the modeling of ongoing studies.
The rapid assembly unit will have 200 beds exclusive for treatment of Covid-19. The new space will hold the Solidarity clinical trial.
Memórias do Instituto Oswaldo Cruz is one of the oldest and most respected scientific journals in Latin America.
The results indicate that infectious diseases were responsible for 30% of deaths in the prison population.